COO
Price
$74.77
Change
-$1.93 (-2.52%)
Updated
Jul 11 closing price
Capitalization
19.72B
45 days until earnings call
NEOG
Price
$5.39
Change
-$0.19 (-3.41%)
Updated
Jul 11 closing price
Capitalization
3.42B
17 days until earnings call
Interact to see
Advertisement

COO vs NEOG

Header iconCOO vs NEOG Comparison
Open Charts COO vs NEOGBanner chart's image
Cooper Companies (The)
Price$74.77
Change-$1.93 (-2.52%)
Volume$2.52M
Capitalization19.72B
Neogen
Price$5.39
Change-$0.19 (-3.41%)
Volume$3.12M
Capitalization3.42B
COO vs NEOG Comparison Chart in %
Loading...
COO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NEOG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COO vs. NEOG commentary
Jul 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COO is a StrongBuy and NEOG is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 13, 2025
Stock price -- (COO: $74.77 vs. NEOG: $5.39)
Brand notoriety: COO and NEOG are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: COO: 92% vs. NEOG: 53%
Market capitalization -- COO: $19.72B vs. NEOG: $3.42B
COO [@Medical Specialties] is valued at $19.72B. NEOG’s [@Medical Specialties] market capitalization is $3.42B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COO’s FA Score shows that 0 FA rating(s) are green whileNEOG’s FA Score has 1 green FA rating(s).

  • COO’s FA Score: 0 green, 5 red.
  • NEOG’s FA Score: 1 green, 4 red.
According to our system of comparison, both COO and NEOG are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COO’s TA Score shows that 4 TA indicator(s) are bullish while NEOG’s TA Score has 4 bullish TA indicator(s).

  • COO’s TA Score: 4 bullish, 5 bearish.
  • NEOG’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, NEOG is a better buy in the short-term than COO.

Price Growth

COO (@Medical Specialties) experienced а +2.01% price change this week, while NEOG (@Medical Specialties) price change was +1.13% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.39%. For the same industry, the average monthly price growth was -0.20%, and the average quarterly price growth was -0.47%.

Reported Earning Dates

COO is expected to report earnings on Aug 27, 2025.

NEOG is expected to report earnings on Sep 30, 2025.

Industries' Descriptions

@Medical Specialties (+0.39% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
COO($19.7B) has a higher market cap than NEOG($3.42B). NEOG has higher P/E ratio than COO: NEOG (150.80) vs COO (68.09). COO YTD gains are higher at: -18.666 vs. NEOG (-55.601). COO has higher annual earnings (EBITDA): 895M vs. NEOG (189M). NEOG has more cash in the bank: 230M vs. COO (135M). NEOG has less debt than COO: NEOG (889M) vs COO (2.77B). COO has higher revenues than NEOG: COO (3.67B) vs NEOG (919M).
COONEOGCOO / NEOG
Capitalization19.7B3.42B577%
EBITDA895M189M474%
Gain YTD-18.666-55.60134%
P/E Ratio68.09150.8045%
Revenue3.67B919M399%
Total Cash135M230M59%
Total Debt2.77B889M312%
FUNDAMENTALS RATINGS
COO vs NEOG: Fundamental Ratings
COO
NEOG
OUTLOOK RATING
1..100
3712
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
97
Overvalued
PROFIT vs RISK RATING
1..100
94100
SMR RATING
1..100
8293
PRICE GROWTH RATING
1..100
5088
P/E GROWTH RATING
1..100
872
SEASONALITY SCORE
1..100
7550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

COO's Valuation (76) in the Medical Specialties industry is in the same range as NEOG (97). This means that COO’s stock grew similarly to NEOG’s over the last 12 months.

COO's Profit vs Risk Rating (94) in the Medical Specialties industry is in the same range as NEOG (100). This means that COO’s stock grew similarly to NEOG’s over the last 12 months.

COO's SMR Rating (82) in the Medical Specialties industry is in the same range as NEOG (93). This means that COO’s stock grew similarly to NEOG’s over the last 12 months.

COO's Price Growth Rating (50) in the Medical Specialties industry is somewhat better than the same rating for NEOG (88). This means that COO’s stock grew somewhat faster than NEOG’s over the last 12 months.

NEOG's P/E Growth Rating (2) in the Medical Specialties industry is significantly better than the same rating for COO (87). This means that NEOG’s stock grew significantly faster than COO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COONEOG
RSI
ODDS (%)
Bearish Trend 2 days ago
51%
Bullish Trend 3 days ago
58%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
50%
Bearish Trend 2 days ago
78%
Momentum
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
51%
MACD
ODDS (%)
Bullish Trend 2 days ago
66%
Bullish Trend 2 days ago
63%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
60%
Bullish Trend 2 days ago
63%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
57%
Bearish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 3 days ago
62%
Bullish Trend 3 days ago
66%
Declines
ODDS (%)
Bearish Trend about 1 month ago
57%
Bearish Trend 16 days ago
78%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
63%
Bearish Trend 2 days ago
74%
Aroon
ODDS (%)
Bullish Trend 2 days ago
54%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
COO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NEOG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VHCOX88.64N/A
N/A
Vanguard Capital Opportunity Inv
MQIFX15.65N/A
N/A
Franklin Mutual Quest Z
PFGEX28.17N/A
N/A
Parnassus Growth Equity Investor
EAGCX19.47N/A
N/A
Eaton Vance Atlanta Capital Focused Gr C
IPFPX53.73N/A
N/A
Poplar Forest Partners Institutional

NEOG and

Correlation & Price change

A.I.dvisor indicates that over the last year, NEOG has been loosely correlated with RVTY. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if NEOG jumps, then RVTY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEOG
1D Price
Change %
NEOG100%
-3.41%
RVTY - NEOG
42%
Loosely correlated
-0.88%
IQV - NEOG
40%
Loosely correlated
-1.65%
SHC - NEOG
39%
Loosely correlated
-0.76%
RDNT - NEOG
38%
Loosely correlated
-3.51%
QTRX - NEOG
38%
Loosely correlated
+0.60%
More